干扰素在肝癌治疗中的应用

被引：12

作者：

张巨波 ^{[1
,2
]}

叶胜龙 ^{[1
,2
]}

机构：

[1] 复旦大学肝癌研究所

[2] 复旦大学中山医院癌变与侵袭原理教育部重点实验室

来源：

中华肝脏病杂志 | 2011年 / 01期

关键词：

干扰素; 肝肿瘤; 治疗;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>干扰素是一种具有广泛生物学活性的细胞因子,不仅具有抗病毒作用,而且具有增强机体抗肿瘤免疫反应、抑制肿瘤血管生成、抗细胞增殖以及诱导细胞分化、凋亡等作用。干扰素家族包括α、β、γ三类,大量研究结果显示,干扰素可以预防慢性病毒性肝炎患者中肝癌的发生,并且具有推

引用

共 9 条

[1]

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma [J].

Singal, A. K. ;

Freeman, D. H., Jr. ;

Anand, B. S. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (07) :851-858

[2]

Meta-analysis: reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C [J].

Miyake, Yasuhiro ;

Iwasaki, Yoshiaki ;

Yamamoto, Kazuhide .

INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (04) :989-996

[3]

Type I Interferon Modulates Monocyte Recruitment and Maturation in Chronic Inflammation [J].

Lee, Pui Y. ;

Li, Yi ;

Kumagai, Yutaro ;

Xu, Yuan ;

Weinstein, Jason S. ;

Kellner, Erinn S. ;

Nacionales, Dina G. ;

Butfiloski, Edward J. ;

van Rooijen, Nico ;

Akira, Shizuo ;

Sobel, Eric S. ;

Satoh, Minoru ;

Reeves, Westley H. .

AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (05) :2023-2033

[4]

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma [J].

Lo, Chung Mau ;

Liu, Chi Leung ;

Chan, See Ching ;

Lam, Chi Ming ;

Poon, Ronnie T. P. ;

Ng, Irene O. L. ;

Fan, Sheung Tat ;

Wong, John .

ANNALS OF SURGERY, 2007, 245 (06) :831-842

[5]

Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial [J].

Sun, Hui-Chuan ;

Tang, Zhao-You ;

Wang, Lu ;

Qin, Lun-Xiu ;

Ma, Zeng-Chen ;

Ye, Qin-Hai ;

Zhang, Bo-Heng ;

Qian, Yong-Bin ;

Wu, Zhi-Quan ;

Fan, Jia ;

Zhou, Xin-Da ;

Zhou, Jian ;

Qiu, Shuang-Jian ;

Shen, Yue-Fang .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (07) :458-465

[6]

Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways [J].

Wu, WZ ;

Sun, HC ;

Shen, YF ;

Chen, J ;

Wang, L ;

Tang, ZY ;

Iliakis, G ;

Liu, KD .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (03) :169-178

[7]

Interferon-alpha in tumor immunity and immunotherapy [J].

Belardelli, F ;

Ferrantini, M ;

Proietti, E ;

Kirkwood, JM .

CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) :119-134

[8]

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential [J].

Wang, L ;

Tang, ZY ;

Qin, LX ;

Wu, XF ;

Sun, HC ;

Xue, Q ;

Ye, SL .

HEPATOLOGY, 2000, 32 (01) :43-48

[9]

Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial [J].

Mazzella, G ;

Saracco, G ;

Festi, D ;

Rosina, F ;

Marchetto, S ;

Jaboli, F ;

Sostegni, R ;

Pezzoli, A ;

Azzaroli, F ;

Cancellieri, C ;

Montagnani, M ;

Roda, E ;

Rizzetto, M .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (08) :2246-2250

← 1 →